Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Therapies for HER2+ Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02945579
What this trial is testing

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Who this might be right for
Estrogen Receptor NegativeHER2 Positive Breast CarcinomaHER2/Neu Negative+9 more
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)WithdrawnNCT04038489
What this trial is testing

COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor-positive Breast Cancer
University of Virginia
Testing effectiveness (Phase 2)Looking for participantsNCT05795101
What this trial is testing

TRUDI: TDXD+Durva in HER2+/Low IBC

Who this might be right for
Invasive Breast CancerInflammatory Breast Cancer Stage IIIHER2-positive Breast Cancer+2 more
Filipa Lynce, MD 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07787338
What this trial is testing

SHR-A1811 Monotherapy or Sequential THPy as Neoadjuvant Therapy for Stage II-III HER2-Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
First Affiliated Hospital of Zhejiang University 80
Large-scale testing (Phase 3)Looking for participantsNCT06913777
What this trial is testing

Neoadjuvant SNF Precision Therapy Phase III

Who this might be right for
Neoadjuvant Therapy
Fudan University 404
Testing effectiveness (Phase 2)Active Not RecruitingNCT06198751
What this trial is testing

Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer

Who this might be right for
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 104
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07047755
What this trial is testing

Trastuzumab Rezetecan Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Who this might be right for
Breast Cancer
Henan Cancer Hospital 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06483386
What this trial is testing

Pyrotinib and Subcutaneous Preparation of Trastuzumab Combined With Capecitabine Neoadjuvant Therapy for HER2+ Study of Breast Cancer

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 109
Large-scale testing (Phase 3)Active Not RecruitingNCT06112379
What this trial is testing

A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 1,902
Not applicableLooking for participantsNCT06087120
What this trial is testing

Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment

Who this might be right for
Breast Cancer FemaleStage II Breast CancerStage III Breast Cancer+2 more
Gene Solutions 125
Testing effectiveness (Phase 2)Study completedNCT03644186
What this trial is testing

To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)

Who this might be right for
Breast CancerEstrogen Receptor Positive TumorHER2-positive Breast Cancer
ETOP IBCSG Partners Foundation 147
Testing effectiveness (Phase 2)UnknownNCT04302441
What this trial is testing

Evaluate Vinorelbine Plus Capecitabine Combined With Trastuzumab for HER2 Positive Patients Following Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Fudan University 550
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07618923
What this trial is testing

Neoadjuvant Dalpiciclib + AI → SHR-A1811 for HR+/HER2-Low Breast Cancer

Who this might be right for
Breast CancerHR Positive/HER2 Low Breast Cancer
Tang-Du Hospital 20
Large-scale testing (Phase 3)Study completedNCT02125344
What this trial is testing

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

Who this might be right for
Tubular Breast Cancer Stage IITubular Breast Cancer Stage IIIMucinous Breast Cancer Stage II+4 more
GBG Forschungs GmbH 961
Testing effectiveness (Phase 2)Study completedNCT01669252
What this trial is testing

Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast Cancer

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 163
Testing effectiveness (Phase 2)UnknownNCT05945368
What this trial is testing

A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC

Who this might be right for
HER2-positive Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 78
Testing effectiveness (Phase 2)Looking for participantsNCT06000917
What this trial is testing

Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast Cancer

Who this might be right for
Breast CancerNeoadjuvant
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 62
Testing effectiveness (Phase 2)Looking for participantsNCT05911958
What this trial is testing

SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer

Who this might be right for
HER2 Low Breast Carcinoma
Henan Cancer Hospital 66
Large-scale testing (Phase 3)Looking for participantsNCT04254263
What this trial is testing

Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer

Who this might be right for
Locally Advanced Breast Cancer
RenJi Hospital 316
Testing effectiveness (Phase 2)Active Not RecruitingNCT00999804
What this trial is testing

Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy

Who this might be right for
Breast Cancer
Baylor Breast Care Center 128
Next Page